Related Experiment Video

Updated: Jan 25, 2026

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors
08:14

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors

Published on: October 28, 2014

13.3K

Generation of three control iPS cell lines for sickle cell disease studies by reprogramming erythroblasts from

Bruno Diaz Paredes1, Gabriele Louise Soares Martins2, Carine Machado Azevedo3

  • 1São Rafael Hospital, D'Or Institute for Research and Education (IDOR), Salvador, BA, Brazil; National Institute of Science and Technology for Regenerative Medicine, Rio de Janeiro, RJ, Brazil.

Stem Cell Research
|May 13, 2019
PubMed

Insights

Researchers generated integration-free induced pluripotent stem cell (iPSC) lines from healthy individuals. These sickle cell disease (SCD) iPSC controls are valuable for studying the genetic disorder.

Area of Science:

  • Stem cell biology
  • Genetics
  • Hematology

Background:

  • Sickle cell disease (SCD) is a severe monogenetic blood disorder.
  • Previous work established patient-derived induced pluripotent stem cell (iPSC) lines.

Purpose of the Study:

  • To generate age-, ethnicity-, and gender-matched healthy control iPSC lines for SCD research.
  • To provide essential controls for comparative studies involving SCD patient-derived iPSCs.

Main Methods:

  • Erythroblasts were expanded from peripheral blood mononuclear cells (PBMCs).
  • Reprogramming to iPSCs was achieved using a non-integrative method.
  • Characterization included pluripotency marker expression, karyotyping, and differentiation potential.

Main Results:

  • Generated three lines of integration-free, healthy control iPSCs.
  • Confirmed pluripotency, normal karyotype, and differentiation capacity into three germ layers.
  • Verified the absence of integration from the reprogramming method.

Conclusions:

  • The generated healthy control iPSC lines are well-characterized and suitable for research.
  • These cell lines will serve as critical matched controls for sickle cell disease studies.
  • Facilitates further investigation into SCD pathogenesis and potential therapeutic strategies.

More Related Videos

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

20.3K
Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

643

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.6K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.4K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.1K
Cell Lines01:16

Cell Lines

A cell line is a population of cells grown in vitro that can be subcultured over several generations. Normal cells cease to divide after a certain number of cell divisions, a process known as replicative senescence. This number, called the Hayflick limit, was conceptualized by Leonard Hayflick in 1961 when he observed that fetal cells grown in culture could only divide 40-60 times. This limit is due to the shortening of the telomeres during each round of cell division, preventing cell division...
10.1K
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.1K
The Cell Cycle Control System01:28

The Cell Cycle Control System

The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
5.5K